SUBSCRIBE
Biohealth Innovation
Founding Member of
SUBSCRIBE
Events Calendar
Beyond the Stethoscope--How MD-MBAs Influence the Current Challenges in Healthcare
The National Capitol Area Chapter of SoPE in concert with Johns Hopkins Carey Business School, MedChi, and Medical Society of Northern Virginia presents:
“Beyond the Stethoscope--How MD-MBAs Influence the Current Challenges in Healthcare”
Telling Our Stories: How physicians have taken the science of business and integrated it with their medical training to accelerate their faculty positions, redefine their careers, change their perspectives and leave a bigger footprint.
FEF Networking Breakfast with Dr. Jim Barrett of NEA and Frank Finelli of The Carlyle Group
FEF Networking Breakfast with Dr. Jim Barrett, General Partner at NEA and Frank Finelli, Managing Director for Corporate Private Equity at The Carlyle Group. NEA is a leading venture capital and venture growth equity firm focused on technology and healthcare. The Carlyle Group is a global alternative asset manager with $148 billion in assets under management in 89 active funds and 52 fund of fund vehicles investing in corporate private equity, real assets, global market strategies and fund of funds solutions.
14th Annual NIH SBIR/STTR Conference
In FY2012, there is now $717M available thanks to the increased SBIR/STTR set-asides afforded to us in the SBIR/STTR Reauthorization. The amount available will increase each and every year through FY2017!
Learn how to access these vital funds for your company at the NIH Annual Conference in Louisville, KY.
Montgomery County Outlook: A Changing Community and a Transformative Opportunity
Have you ever wondered what the future holds for Montgomery County, a community of one million people among the best educated in the world with unrivaled bio-health research infrastructure? What would in be like in 10, 20, or 30 years? Too busy for town hall meetings, public hearings or even the news?
Join us for a special program, "Montgomery County Outlook: A Changing Community and a Transformative Opportunity," to learn about an exciting new public-private partnership to drive technology-based economic development and the vision to turn what used to be a bedroom community into a 21st century community and a global destination for innovation.
Health Data Initiative Forum III-The Health Datapalooz
Plug into the Ecosystem of Health Innovation. Bring creative ideas, and connect with startups, developers, and designers. Learn how to utilize the exploding market of healthcare data innovation, and network with recognized VCs, funders, policy makers, and potential partners.
The Health Datapalooza will feature keynote addresses, a Data & Apps Expo, demonstrations of cutting-edge apps, hands-on data deep dives, and thought-provoking panel discussions. There will also be plenty of time for networking and one-on-one interaction.
InvestMaryland Forum
Thursday, June 14, 2012 from 10:00 AM to 12:00 PM (ET)
Rockville, MD
A free and open forum to:
- Discuss InvestMaryland implementation progress and investment strategy
- Detail state venture funding resources to seed and early-stage companies
- Address questions from the business community
Presenters:
- Johns Hopkins University
- Maryland Department of Business & Economic Development
- Maryland Venture Fund Authority
2012 BIO International Convention - Boston
Thousands of companies from around the world and all industry segments will be at BIO, ready to build strategic partnerships. Attend the Global Event for Biotechnology and you will reap the benefits of an efficient four days! You will find connections, partnering and innovation everywhere at BIO. 15,000+ leaders from more than 65 countries come to this global gathering. We invite you to join!
BIO covers the wide spectrum of life science innovations and application areas. Drug discovery, biomanufacturing, genomics, biofuels, nanotechnology, and cell therapy are just a few of the industries represented at the BIO International Convention.
We have a free service, myBIO Personal Event Planner - search using keywords to find what interests you at BIO.
The key elements of the event are education,networking, BIO Business Forum partnering and the 1,800 companies showcasing the latest technologies, products and services in the BIO Exhibition. See the Schedule of Events.
More InformationCANCER VACCINES & ACTIVE IMMUNOTHERAPEUTICS: 3rd Annual Summit
Download the Brochure | Register Now
Dendreon hit all the headlines when Provenge got approval. Then Ipilimumab. And just beneath the surface, a host of others are starting to make waves. With MAGE, PROSTVAC and several other products knocking on the door of market approval, what are you doing to ensure your drug reaches these heights?
Designed by Merck Serono, Immatics Biotechnologies, DCPrime, MedImmune, FDA, Oxford Biomedica and many others, the Cancer Vaccines & Active Immunotherapeutics 3rd Annual Summit will bring together key opinion leaders to discuss and debate different approaches to help you navigate the clinic, boost the immune response and jump over every regulatory hurdle en route to market.
With a strong focus on combination approaches, novel adjuvants and immunomodulators, you will leave the meeting armed with the best strategies to develop successful anti-cancer drugs. Our other Cancer Vaccines meetings were acclaimed by delegates for doing just that.
iTEC Webinar Series with Rich Bendis - A Review of the Federal Government's Entrepreneurial Initiatives with guest Nish Acharya - Monday, August 13, 12:00 pm to 12:30pm ET
A Review of the Federal Government's Entrepreneurial Initiatives
Monday, August 13, 12:00 pm to 12:30pm ET
Richard Bendis and Nish Acharya will talk about the innovation and entrepreneurship programs in Federal Government today. Nish will also discuss briefly the status of the EDA i6 competition and the noticeable increase in the quality of the proposals.
They will speak about the paradigm shift in the EDA programs from a "Bricks and Mortar" focus (hard) to a more innovative programmatic focus (soft) on innovation, commercialization and entrepreneurship.
They will also discuss the convergence of Universities, Government/ NIST and industry in the formation of private/public/partnerships to implement strategic innovation based economic development initiatives on a regional basis.
Business of Bio @ The BioPark - Wednesday, September 5 at 10:30am to 1:00pm
University of Maryland BioPark, Life Sciences Conference Center
Meet with Bahija Jallal, Ph.D., Executive Vice President of Research and Development, MedImmune The Changing Face of the Biopharmaceutical Industry—Creating a Culture of Innovation
The biopharmaceutical industry is not the same as it was even a decade ago. Today, there are even more pressures to produce not just safe and effective drugs but safe and effective drugs that the payers are willing to pay for. We also know that research and development costs are increasing while R&D productivity continues to be on the decline. How can we continue to make it in the industry when our ultimate goal is to provide much needed drugs to patients with unmet medical needs?